Evidence map›Paper›PMID 39673494›Full record

ArticleGlycobiology2025

Differential substrate preferences IN ACTINOBACTERIAL protein O-MANNOSYLTRANSFERASES and alteration of protein-O-MANNOSYLATION by choice of secretion pathway.

Hirak Saxena, Rucha Patel, John Kelly, Warren Wakarchuk

Abstract read
In one paragraph

Article in Glycobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hirak SaxenaDepartment of Biological Sciences, University of Alberta, 116 St & 85 Ave, Edmonton, AB T6G 2R3.
Rucha PatelDepartment of Biological Sciences, University of Alberta, 116 St & 85 Ave, Edmonton, AB T6G 2R3.
John KellyHuman Health Therapeutics, National Research Council of Canada, 100 Sussex Dr, Ottawa, ON K1N 1J1.ORCID 0000-0003-1998-3572
Warren WakarchukDepartment of Biological Sciences, University of Alberta, 116 St & 85 Ave, Edmonton, AB T6G 2R3.ORCID 0000-0002-1539-1679

Funding

Natural Sciences and Engineering Research Council RGPIN-2019-04640
6 · The paper itself

Abstract

Protein-O-mannosylation (POM) is a form of O-glycosylation that is ubiquitous and has been studied extensively throughout in fungi and animals. The key glycosyltransferase, protein O-mannosyltransferase (PMT), a member of family GT-39, is also found in over 3,800 bacterial genomes but has only been minimally examined from prokaryotes. In prokaryotes POM has only been investigated in terms of pathogenicity (in Mycobacterium tuberculosis) even though there are far more non-pathogenic bacteria that appear to carry out POM. To date, there is no consensus on what benefit POM imparts to the non-pathogenic bacteria that can perform it. Through the generation of a POM deficient mutant of Corynebacterium glutamicum - a widely utilized and known protein O-mannosylating actinobacteria - this work shows that even closely related actinobacterial GT-39 s (the enzymes responsible for the initiation of POM) can have different substrate specificities for targets of POM. Moreover, presented here is evidence that POM does not only occur in a SEC-dependent manner; POM also occurs with TAT and non-SEC secreted substrates in a specific and likely tightly regulated manner. Together these results highlight the need for further biochemical characterization of POM in these and other bacterial species to help elucidate the true nature of its biological functions.

Indexed as

Bacterial ProteinsCorynebacterium glutamicumMannosyltransferasesGlycosylationSecretory PathwaySubstrate SpecificityBacterial ProteinsMannosyltransferasesprotein O-mannosyltransferaseActinobacteriaProtein-o-mannosylationProtein-o-mannosyltransferase

Identifiers

PMID39673494
PMCPMC11727336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.